TIGIFY

Serial Number 87354452
601

Registration Progress

Application Filed
Mar 1, 2017
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: TIGIFY
Previous Owner: Pfizer Inc.
Classes: 005

Trademark Image

TIGIFY

Basic Information

Serial Number
87354452
Filing Date
March 1, 2017
Abandonment Date
February 15, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Feb 16, 2018
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Legal Representation

Attorney
Heather McDonald

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

15 events
Date Code Type Description Documents
Feb 16, 2018 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
Feb 16, 2018 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Feb 15, 2018 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Oct 2, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 2, 2017 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 2, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 29, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 29, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 29, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 10, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 10, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 10, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 8, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 4, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005